Preventive Medication Nirsevimab Was Highly Effective at Protecting Children from Severe RSV Illness, Study Finds
In 2023-2024, the preventive medicine called nirsevimab was highly effective at protecting young children against severe respiratory syncytial virus (RSV) infections, a new study found.